1 completed, 1 terminated. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Terminated 1 |
Follow Quantum Genomics SA: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Randomized Study of Extended Treatment With Firibastat in Treatment-Resistant Hypertension (REFRESH) Firibastat (QGC001) Period 1 - Hypertension (HTN) | Phase 3 | Terminated | Quantum Genomics SA | 419 | 2021-08-05 | 2023-01-17 |
| Firibastat in Treatment-resistant Hypertension Firibastat, Placebo - Hypertension | Phase 3 | Completed | Quantum Genomics SA | 515 | 2020-06-25 | 2022-10-20 |
Hypertension (2)
firibastat (2)
United States (2) · Canada (1) · Czechia (1) · France (1) · Germany (1) · Poland (1) · Spain (1)